AAAAAA

   
Results: 1-9 |
Results: 9
Dual cell seeding and the use of zymogen tissue plasminogen activator to improve cell retention on polytetrafluoroethylene grafts
Authors: Yu, H Wang, Y Eton, D Rowe, VL Terramani, TT Cramer, DV Starnes, VA Weaver, FA
Citation: H. Yu et al., Dual cell seeding and the use of zymogen tissue plasminogen activator to improve cell retention on polytetrafluoroethylene grafts, J VASC SURG, 34(2), 2001, pp. 337-343
Human macrovascular endothelial cells: Optimization of culture conditions
Authors: Terramani, TT Eton, D Bui, PA Wang, Y Weaver, FA Yu, H
Citation: Tt. Terramani et al., Human macrovascular endothelial cells: Optimization of culture conditions, IN VITRO-AN, 36(2), 2000, pp. 125-132
Staged thoracic and abdominal aortic aneurysm repair using stent graft technology and surgery in a patient with acute renal failure
Authors: Eton, D Terramani, TT Katz, M
Citation: D. Eton et al., Staged thoracic and abdominal aortic aneurysm repair using stent graft technology and surgery in a patient with acute renal failure, ANN VASC S, 14(2), 2000, pp. 114-117
High efficiency in vitro gene transfer into vascular tissues using a pseudotyped retroviral vector without pseudotransduction
Authors: Yu, H Eton, D Wang, Y Kumar, SR Tang, L Terramani, TT Benedict, C Hung, G Anderson, WF
Citation: H. Yu et al., High efficiency in vitro gene transfer into vascular tissues using a pseudotyped retroviral vector without pseudotransduction, GENE THER, 6(11), 1999, pp. 1876-1883
The role of heparin-associated antiplatelet antibodies in the outcome of arterial reconstruction - Discussion
Authors: Hoch, J Calaitges, JG Eton, D Shepard, A Sicard, G
Citation: J. Hoch et al., The role of heparin-associated antiplatelet antibodies in the outcome of arterial reconstruction - Discussion, J VASC SURG, 29(5), 1999, pp. 785-786
Genetic engineering of stent grafts with a highly efficient pseudotyped retroviral vector
Authors: Eton, D Terramani, TT Wang, Y Takahashi, AM Nigro, JJ Tang, LL Yu, H
Citation: D. Eton et al., Genetic engineering of stent grafts with a highly efficient pseudotyped retroviral vector, J VASC SURG, 29(5), 1999, pp. 863-873
Genetic engineering of stent grafts with a highly efficient pseudotyped retroviral vector - Discussion
Authors: Sicard, G Eton, D Matsumura, J Holden, C
Citation: G. Sicard et al., Genetic engineering of stent grafts with a highly efficient pseudotyped retroviral vector - Discussion, J VASC SURG, 29(5), 1999, pp. 873-873
Retroviral vector-mediated transfer and expression of human tissue plasminogen activator cDNA in bovine brain endothelial cells
Authors: Yu, H Wang, Y Eton, D Stins, M Wang, L Apuzzo, MLJ Weaver, FA McComb, JG Weiss, MH Zlokovic, BV
Citation: H. Yu et al., Retroviral vector-mediated transfer and expression of human tissue plasminogen activator cDNA in bovine brain endothelial cells, NEUROSURGER, 45(4), 1999, pp. 962-968
Research report a preliminary analysis of medical futility decisionmaking:Law and professional attitudes
Authors: Wiener, RL Eton, D Gibbons, VP Goldner, JA Johnson, SH
Citation: Rl. Wiener et al., Research report a preliminary analysis of medical futility decisionmaking:Law and professional attitudes, BEH SCI LAW, 16(4), 1998, pp. 497-508
Risultati: 1-9 |